申请人:ALMIRALL SA
公开号:WO2017060488A1
公开(公告)日:2017-04-13
The present invention relates to compounds of Formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by TRPA1 channel inhibition or antagonism.
本发明涉及式(I)的化合物,以及制备这种化合物的方法,以及它们在治疗通过TRPA1通道抑制或拮抗可改善的病理状况或疾病中的用途。